This is consistent with the previously reported mechanism of MEK/ERK/p90RSK pathway regulation of cell-cycle progression and migration52, 53, 54, 55, further indicating that MEK mediates MAP3K8 effects on the proliferation and motility of ovarian cancer cells. This evidence concerns the gene RPS6KA1 and ovarian carcinoma.